Back to top

Clear Street Sticks to Its Buy Rating for Summit Therapeutics (SMMT)

In a report released today, from Clear Street maintained a Buy rating on Summit Therapeutics, with a price target of $31.00. In addition to Clear S...

Read full article here »

In-Depth Zacks Research for the Tickers Above

Normally $25 each - click below to receive one report FREE:

Summit Therapeutics PLC (SMMT)